Listen

Description

This month Guardant Health became the first company to get its liquid biopsy test, the Guardant 360, covered by a health insurance company. CEO Helmy Eltoukhy, spoke to MedTech Insight about the mile-marker and said other laboratory test developers need to get on FDA's LDT regulatory bandwagon for everyone's best interest.